Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer
Clinical trial NCT05305131 · RECRUITING
Trial details
- NCT number
- NCT05305131
- Sponsor
- National University Hospital, Singapore
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-28
- Primary completion
- 2025-12-28
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.